OpenAlex
PricingAboutJobs
Log inGet started
Work

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study

HTML PDF

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of the Rheumatic Diseases
DOI: 10.1136/ard.2010.144063
Authors: Naomi Schlesinger, Eduardo Mysler, Hsiao-Yi Lin, Marc De Meulemeester, Jozef Rovensky, Udayasankar Arulmani, Alison Balfour, Gerhard Krammer, Peter Sallstig, Alexander So
Institutions: University of Medicine and Dentistry of New Jersey, Taipei Veterans General Hospital, National Yang Ming University, Novartis (Switzerland), Centre Hospitalier Universitaire Vaudois
Language: English

Topic: Gout, Hyperuricemia, Uric Acid
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: canakinumab, gout, allopurinol, urate-lowering therapy, IL-1β, colchicine, dose-response relationship, adverse events
SDG: Good health and well-being

Open Access status: bronze

Funder: Novartis Pharma
OpenAlex ID: W2137091038
FWCI: 19.94
Cites: 32
Cited by: 248
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms